Europe — EMA
Nimbex (Cisatracurium)
GNH USA supplies Nimbex (Cisatracurium), a non-depolarizing neuromuscular blocker for intubation, surgical muscle relaxation, and mechanical ventilation.
Request sourcing
What is Cisatracurium?
Cisatracurium, the active ingredient in Nimbex, is a non-depolarizing neuromuscular blocking agent presented as an injectable solution for intravenous use. It facilitates endotracheal intubation, provides skeletal muscle relaxation during surgery, and supports controlled mechanical ventilation in adult patients undergoing anesthesia or intensive care.
GNH USA supplies Nimbex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.
What is Cisatracurium used for?
Cisatracurium is a non‑depolarizing neuromuscular blocker used in peri‑operative and critical‑care settings.
Endotracheal intubation: provides rapid muscle relaxation to facilitate tube placement. Surgical procedures: maintains skeletal muscle relaxation throughout the operation. Mechanical ventilation: enables controlled ventilation by preventing spontaneous breathing efforts.
What are the side effects of Cisatracurium?
Cisatracurium may be associated with a range of adverse reactions, which are categorized by frequency and severity.
Common Side Effects: - Flushing - Tachycardia - Transient hypotension - Histamine release
Serious or Rare Side Effects: - Anaphylaxis - Prolonged neuromuscular blockade - Severe hypotension or cardiovascular collapse - Respiratory depression requiring intervention
What precautions apply to Cisatracurium?
When using cisatracurium, clinicians should observe several safety considerations to minimize risk.
Dose adjustment: consider renal or hepatic impairment, as elimination may be altered. Monitoring: continuous neuromuscular monitoring is recommended to assess depth of block. Contraindications: avoid in patients with known hypersensitivity to cisatracurium or related compounds. Pregnancy: use only if the potential benefit justifies the potential risk (Category B). Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Cisatracurium interact with?
Cisatracurium can interact with other agents that influence neuromuscular transmission or cardiovascular function.
Major Interactions (Avoid): - Aminoglycoside antibiotics: potentiate neuromuscular blockade. - Lithium: may enhance the paralytic effect. - Magnesium sulfate: increases susceptibility to blockade. - Volatile anesthetics: produce synergistic muscle relaxation.
Moderate Interactions (Monitor Closely): - Beta‑adrenergic blockers: may affect heart rate response during blockade. - Calcium channel blockers: can alter hemodynamic stability.
